Navigation Links
Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
Date:1/3/2008

DANBURY, Conn., Jan. 3 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has completed enrollment of its two pivotal Phase III clinical trials of VIAject(TM), a rapid-acting injectable meal-time insulin for use by patients with Type 1 and Type 2 diabetes. The Company also announced its intention to build and operate a fill and finish manufacturing facility for VIAject(TM), on the campus of its current headquarters in Danbury, Connecticut.

"We are pleased to have completed enrollment of the VIAject(TM) clinical trials on schedule," commented Solomon S. Steiner, Ph.D., Chairman and Chief Executive Officer of Biodel. "We believe that VIAject(TM)'s superior pharmacokinetic and pharmacodynamic profile should improve the treatment of millions of patients with diabetes."

Biodel has now enrolled over 400 patients with Type 1 diabetes at approximately 60 clinical sites in the United States, Europe, and Asia, and over 400 patients with Type 2 diabetes at approximately 50 clinical sites in the United States, Europe, and Asia. Both studies are multi-center, open label and six months in duration, comparing the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human insulin. Biodel expects to complete these trials and, if the trials are successful, the Company intends to submit a New Drug Application for VIAject(TM) to the Food and Drug Administration by the end of 2008.

To prepare for commercialization of VIAject(TM), the Company plans to build a fill and finish manufacturing facility which will be dedicated to manufacturing a full line of VIAject(TM) liquid formulations and presentations. The dedicated manufacturing facility will improve margins, provide superior quality control, and better inventory control. Biodel anticipates that the facility will cost under $15 million and will be available for commercial production in 2009.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceuti
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
3. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
4. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
5. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
6. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
7. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
8. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
9. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
10. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
11. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNe...nc. ("China Sky One Medical" or "the Company") (Na...utical company developing and producing,over-the-c...RC"), today,announced that the Company recently pa...l of Pharmaceutical and Biological Products ("ICPB...
(Date:11/25/2009)..., , WALTHAM, Mass., Nov. 25 /PRNews...RG), the global authority on medical technology ma... for trauma fixation devices will continue to see ...recent economic slowdown. MRG,s US Markets for Tr... will remain highly dynamic over the next five yea...
(Date:11/25/2009)..., , DELFT, The Netherlands and JOH...rmaceuticals, service division and Pyxis Discovery...tive agreement to jointly market both,companies, s...nal chemistry and lead discovery expertise,will be...e medicinal and,synthetic chemistry support to pro...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2UNH researcher receives presidential environmental award 8894 1UNH researcher receives presidential environmental award 8894 2Millstone Medical Outsourcing Expands Capacity Enhances Loaner Kit Processing Services with New Equipment 49374 1Millstone Medical Outsourcing Expands Capacity Enhances Loaner Kit Processing Services with New Equipment 49374 2Heritage Valley Health System Selects Allscripts Electronic Health Record 49370 1Heritage Valley Health System Selects Allscripts Electronic Health Record 49370 2Heritage Valley Health System Selects Allscripts Electronic Health Record 49370 3Heritage Valley Health System Selects Allscripts Electronic Health Record 49370 4Heritage Valley Health System Selects Allscripts Electronic Health Record 49370 5
... Dr. Roger Kenneth,Hershline PhD MD, the CEO of G...n of the not-for-profit public charity CureHIV.us,...nd Melinda Gates for funding from their,Grand Chal...l be used to,begin clinical studies of a new drug ...drug is also known as compound NIAID #11039 and ha...
...retinal Brachytherapy as NeoVista P...CH, Fla., March 28 NeoVista, Inc. released,today ...ar feasibility,study of the company,s novel epiret... macular degeneration (AMD) at the 31st Annual Mac...omising data from the study, which,was initiated b...
Other Medicine Technology:CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR 2NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 2NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 3
(Date:11/26/2009)..., NEW YORK, Nov. 27 With cold an...r to employ good practices to control the spread o...be proactive not only to keep ourselves healthy, b...aid Eileen Finerty, RN, MS, CIC (certified in infe...trol and occupational health at Hospital for Speci...
(Date:11/26/2009)...that,s too big or too heavy can lead to strains or...News) -- There may be nothing wrong with stuffing ...nt to do the same thing with your suitcase as you ...le were treated in 2008 in U.S. hospital emergency...l facilities for luggage-related injuries, such as...
(Date:11/26/2009)... Research Triangle Dental (RTDent...rth Carolina, today announced the expansion of its...NEER Dentist, Dr. Doug Macmillan. , ...gle Dental is pleased to announce that Dr. Doug Ma...tly completed an additional advanced training semi...
(Date:11/25/2009)..., KANSAS CITY, Mo., Nov. 25 The...come the nation,s largest medical clinic on Dec. 9... of massive free clinics for uninsured people. ,... the biggest one yet, because it will extend over ...ys instead of over a weekend," Sheri Wood, executi...
(Date:11/25/2009)..., LONG BEACH, Calif., Nov. 25 Th...y 1,000 homebound seniors in the greater Long Beac...for Aging, a program operated by Independence at H...e than 17 years these organizations have gathered ...g meals to seniors in need in Long Beach, Lakewood...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...etary pattern is often difficult and often the bar...oices: Can I have eggs for breakfast? Is oatmeal b...ices are important, provided they fit into a sound...examined the effect of dietary patterns, rather th...
...epartment of Energy's Pacific Northwest National L...ne shows that the damage in neurodegenerative dise...ion called nitration. It was explained that Parkin...d to oxidative stress, the cell damage that is usu...
...fessor has set aside all the popular opinion by sa...healthy--than wine, bringing cheers// to all the b...e food science department at the University of Cal...B12, folic acid and niacin, as well as antioxidant...
... Organisation (WHO) has said that the risk of the ...igh. In a report analyzing 205 infections that occ...ince the human infections have peaked in winter an...e in cases could be anticipated starting in late 2...
...un National Aids Control Organisation (NACO) Frida...RV) drugs to 100,000 people with HIV by 2007. // ... 35,000 patients and we plan to give it to 100,000... and the number of centres would be increased to 1...
...llows breast cancer cells to evade the body’s natu...ancer therapies//, according to a study by Keck Sc.... The study, published in the July 1 issue of...t aspect of this study is that … if we turn the pr...
Other Medicine News:Health News:Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases 2Health News:Beer is More Healthier Than Wine 2Health News:Researchers Investigate Protein that Protects Tumors 2
Lpulsa SYL9000 Ophthalmic Yag Laser
Focus Dailies Progressives
...splay of corneal layers: endothelium, descemet's m...ers. Accurate analysis of corneal components: endo...basal & superficial cells. Broad applications in s...gery interface evaluation, endothelial cell analys...
Ahmed Glaucoma Valve (small size)
Medicine Products: